- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
LDAH antibody targets Lipid droplet-associated serine hydrolase, a cytoplasmic protein that localizes to intracellular lipid droplets and participates in lipid metabolism and neutral lipid homeostasis. LDAH is also referred to in the literature as esterase D-like protein or neutral cholesterol ester hydrolase-like protein, reflecting its predicted enzymatic activity within lipid-rich cellular compartments. The protein is enriched at the surface of lipid droplets, where it is positioned to regulate lipid storage and mobilization in metabolically active cells.
Lipid droplets are dynamic organelles involved in energy storage, membrane lipid supply, and signaling lipid regulation. Proteins such as Lipid droplet-associated serine hydrolase contribute to the controlled turnover of lipid droplet contents, balancing lipid accumulation with utilization. LDAH contains a conserved serine hydrolase motif, supporting its proposed role in hydrolyzing neutral lipid substrates, including cholesterol esters and related lipid species. Through this activity, LDAH influences intracellular lipid composition and cellular metabolic state.
LDAH expression has been reported in multiple tissues with active lipid metabolism, including liver, adipose tissue, and steroidogenic organs. At the cellular level, LDAH antibody staining is typically observed in a cytoplasmic pattern associated with lipid droplet-rich regions rather than uniform diffuse cytosol. This distribution aligns with its functional association with lipid droplets and distinguishes LDAH from soluble cytosolic esterases. Altered lipid droplet regulation involving LDAH has been investigated in the context of metabolic disorders, inflammation, and cancer-associated lipid reprogramming.
In cancer biology, lipid droplet-associated enzymes such as LDAH have gained interest due to their roles in supporting rapid cell growth, membrane biosynthesis, and stress adaptation. Dysregulated lipid storage and mobilization are hallmarks of many tumor types, and LDAH expression has been linked to changes in lipid droplet abundance and composition in transformed cells. Detection of LDAH expression provides insight into lipid metabolic states and organelle-associated enzymatic activity within tumor and non-tumor tissues.
This LDAH antibody is suitable for research applications aimed at detecting Lipid droplet-associated serine hydrolase expression and localization in cells and tissue sections. The antibody supports investigation of lipid droplet biology, intracellular lipid metabolism, and the role of serine hydrolases in metabolic regulation. Use of an LDAH antibody enables researchers to study lipid-associated pathways in physiological and disease-relevant experimental systems.
Optimal dilution of the LDAH antibody should be determined by the researcher.
An E.coli-derived human recombinant protein (amino acids E7-D281) was used as the immunogen for the LDAH antibody.
After reconstitution, the LDAH antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.